Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 165, 55-64
Abstract
No abstract availableKeywords
Funding Information
- Progetto di Ricerca di Ateneo 2014 (PDA141311)
- Associazione Italiana per la Ricerca sul Cancro (IG18855)
- Marie Skłodowska-Curie Individual Fellowship (798105)
- FINDER
- University of Perugia
This publication has 67 references indexed in Scilit:
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 VirusesIn VitroJournal of Virology, 2013
- Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B VirusesAntimicrobial Agents and Chemotherapy, 2012
- Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymeraseProceedings of the National Academy of Sciences, 2012
- Disruption of the Viral Polymerase Complex Assembly as a Novel Approach to Attenuate Influenza A VirusJournal of Biological Chemistry, 2011
- Identification of High-Affinity PB1-Derived Peptides with Enhanced Affinity to the PA Protein of Influenza A Virus PolymeraseAntimicrobial Agents and Chemotherapy, 2011
- Influenza Virus Evolution, Host Adaptation, and Pandemic FormationCell Host & Microbe, 2010
- Structural insight into the essential PB1–PB2 subunit contact of the influenza virus RNA polymeraseThe EMBO Journal, 2009
- Crystal structure of the polymerase PAC–PB1N complex from an avian influenza H5N1 virusNature, 2008
- The contents of the syringeNature, 2008
- Peptide-Mediated Interference with Influenza A Virus PolymeraseJournal of Virology, 2007